HighLife Medical is a structural heart company and has developed a system to replace mitral valves via a trans-apical or trans-septal approach.
Location: France, Ile-de-France
Employees: 11-50
Total raised: $50.8M
Founded date: 2010
Investors 4
| Date | Name | Website |
| - | US Venture... | usvp.com |
| - | Sofinnova ... | sofinnovap... |
| - | Andera Par... | anderapart... |
| - | VI Partner... | vipartners... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 17.01.2019 | Series B | $36.47M | - |
| 30.10.2017 | - | $14.33M | - |
Mentions in press and media 11
| Date | Title | Description | Source |
| 21.12.2020 | Significant agreements with Chinese market leaders in our Li... | Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Ce... | anderapart... |
| 21.12.2020 | Significant agreements with Chinese market leaders in our Li... | Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Ce... | anderapart... |
| 01.02.2019 | 10 notable European tech startups that got maximum funding i... | The European tech scene is a thriving community for the startups and aspiring entrepreneurs. Several... | siliconcan... |
| 22.01.2019 | French health tech startup HighLife closes a €32M round B fi... | With every passing day, the number of cardiac patients are escalating globally. Mitral regurgitation... | siliconcan... |
| 18.01.2019 | Paris-based HighLife raises €32 million Series B for its dev... | Paris-based HighLife SAS is a medtech company developing a treatment for patients suffering from mit... | eu-startup... |
| 18.01.2019 | Daily funding roundup - January 18th, 2019 | Vinebox raised $5.9M; HyperScience raised $30M; Limelight Health raised $33.5M SimplyCook: SimplyCo... | vator.tv/n... |
| 18.01.2019 | Term Sheet — Friday, January 18 | WALL STREET’S UNLIKELY STAR Good morning, Term Sheet readers. Paid Content You can't secure what y... | fortune.co... |
| 18.01.2019 | HighLife Closes €32M Series B Financing Round | HighLife SAS, a Paris, France-based medtech company focused on the development of a transcatheter mi... | finsmes.co... |
| 17.01.2019 | HighLife raises $36m Series B for mitral valve replacement | - | usvp.com/n... |
| 31.10.2017 | Term Sheet — Tuesday, October 31 | DEAD AND GONE Good morning, Term Sheet readers. Paid Content How can you protect what you can't se... | fortune.co... |
Show more